Current sickle cell disease (SCD) trial eligibility criteria exclude most adults, with only 9.9% meeting inclusion thresholds ...

Historically characterized by excessive daytime sleepiness and cataplexy, narcolepsy is increasingly recognized as a ...

First, the AASM guideline recommends a combination of CBT‑I and medication over medication alone for adults with chronic ...

Phase 1 BALLI-01 trial results showed promising UCART22 activity in R/R B-cell ALL, with higher remission rates after a ...

Tebipenem pivoxil becomes the only FDA-approved oral carbapenem for complicated UTIs/pyelonephritis in adults lacking viable ...

Standardized order sets, clinical team training on toxicity grading and treatment algorithms, and immediate access to ...

Alexander Spira, MD, PhD, medical oncologist at Virginia Cancer Specialists and chief scientific officer of NEXT Oncology, ...

Prolonged follow-up showed superior PFS with mosun-pola versus R-GemOx in the overall SUNMO population (HR, 0.41) alongside ...

This analysis compared health care resource utilization and costs for Medicaid patients with serious mental illness between ...

Implementation barriers remain largely programmatic, requiring integrated HIV testing, adherence support, STI services, and ...

After decades of neglect, malnutrition-related diabetes, or type 5, is finally getting the research, recognition, and ...

Walcker will oversee enterprise strategy, operations, and growth at The Specialty Alliance, while James Weber, MD, focuses on ...